Filing Flows › Retractable Technologies (RVP) › How it makes money
How Retractable Technologies (RVP) makes money
Retractable Technologies (RVP) made $7.2M of revenue in the second quarter 2026 (Q2 2026), -31% from a year earlier. Syringes brought in $6.3M (87%); EasyPoint Needles brought in $646K (9%); Blood Collection Products brought in $296K (4%).
Drawing the Sankey…
Revenue by segment, Q2 2026
| Segment | Revenue | Share | Q/Q | Y/Y |
|---|---|---|---|---|
| Syringes | $6.3M | 86.8% | +8% | +5% |
| EasyPoint Needles | $646K | 9.0% | -35% | -85% |
| Blood Collection Products | $296K | 4.1% | -21% | -2% |
| Other Products | $8K | 0.1% | +10% | -60% |
Where each dollar of revenue goes
| Line | Q2 2026 | % of revenue |
|---|---|---|
| Revenue | $7.2M | 100.0% |
| Income tax | $2K | 0.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q2 2026 | $7.2M | -31% |
| Q1 2026 | $7.2M | -14% |
| Q4 2025 | $9.4M | +4% |
| Q3 2025 | $10.1M | -2% |
| Q2 2025 | $10.4M | +73% |
| Q1 2025 | $8.3M | +9% |
| Q4 2024 | $9.1M | -36% |
From Retractable Technologies' 10-Q filed Aug 14, 2026 (on EDGAR).
Questions
How does Retractable Technologies make money?
Retractable Technologies (RVP) made $7.2M of revenue in the second quarter 2026 (Q2 2026), -31% from a year earlier. Syringes brought in $6.3M (87%); EasyPoint Needles brought in $646K (9%); Blood Collection Products brought in $296K (4%).
What is Retractable Technologies' biggest business?
Syringes: $6.3M in the second quarter 2026, 87% of revenue, +5% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.